SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Gene Voss who wrote (2581)11/18/1997 5:36:00 AM
From: BigKNY3  Read Replies (2) | Respond to of 23519
 
Gene: <<To believe this or any agent is innocous is ridiculous.>>

Gene, how do explain the summary data of the Viagra clinical studies that is currently being reviewed by the FDA and made public by Pfizer?

The database of 4,500 men (including 550 patients who received Viagra for over a year) indicated the following:
-"The discontinuation rates due to side effects are low, similar to placebo".
-"There are no reports of priapism."
-"The most common side effects were mild headache and flushing."

Based on a review of this summary data, a very influential and respected pharmaceutical stock analyst concluded: "Viagra efficacy is impressive and side effects are unusally low."

BigKNY3



To: Gene Voss who wrote (2581)11/18/1997 1:46:00 PM
From: Bull-like  Read Replies (1) | Respond to of 23519
 
Gene, please, PDE5 is an intracellular enzyme, it has no receptors of any kind whatsoever. PDE5 is selectively expressed in CNS, heart, lung, testis, etc. But definitely not everywhere.

My statement has nothing to do with the side effects or efficacy of
Viagara, just simply correct your false statement.

Da bull


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News